(Q87408711)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25034977%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Phase I clinical trial of pegylated liposomal mitoxantrone plm60-s: pharmacokinetics, toxicity and preliminary efficacy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25034977%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

main subject

phase I clinical trial

1 reference

1 reference

Jianliang Yang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25034977%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Yuankai Shi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25034977%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Chunlei Li

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25034977%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Lin Gui

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25034977%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Xi Zhao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25034977%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Peng Liu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25034977%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Xiaohong Han

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25034977%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Yuanyuan Song

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25034977%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Ning Li

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25034977%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Ping Du

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25034977%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Shuxiang Zhang

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25034977%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

18 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25034977%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

9 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25034977%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25034977%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25034977%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

637-646

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25034977%20AND%20SRC:MED&resulttype=core&format=json

10.1007/S00280-014-2523-8

9 March 2020

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25034977%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference